Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Neoplasms of the CNS

Free Subscription 22.12.2025 1 AJNR Am J Neuroradiol 1 BMC Cancer 1 BMC Neurol 2 Cancer 2 Cancer Res 1 Childs Nerv Syst 1 Clin Neuropathol 1 Int J Cancer 7 J Neurooncol 1 J Neuropathol Exp Neurol 4 Neuro Oncol 1 Neurology 1 Neurosurgery 1 Oncogene 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. AHMADZADEH AM, Broomand Lomer N, Ghaderi S, Afarideh Sani M, et al
   Differentiating Glioma from Brain Metastasis Using Neurite Orientation Dispersion and Density Imaging; A Systematic Review and Meta-Analysis.
   AJNR Am J Neuroradiol. 2025 Dec 18:ajnr.A9148. doi: 10.3174/ajnr.A9148.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. ALHALABI A, Abdo T, Hijazi A, Mohanna M, et al
   Factors associated with developing and surviving brain metastases in patients with breast cancer: a multi-center experience.
   BMC Cancer. 2025 Dec 19. doi: 10.1186/s12885-025-15422.
   PubMed         Abstract available
   
   

   
   BMC Neurol

3. LIU X, Luo D, Zhang P, Tian D, et al
   A computational analysis of programmed cell death-associated LncRNA signatures in glioma and drug prediction.
   BMC Neurol. 2025;25:509.
   PubMed         Abstract available
   
   

   
   Cancer

4. LAWRENCE L
   Diffuse midline gliomas get first FDA-approved drug.
   Cancer. 2025;131:e70146.
   PubMed        
   
   
5. 
   Correction to "Determinants of geographic variation in the incidence of adult nonmalignant meningioma in the United States, 2010-2019".
   Cancer. 2025;131:e70206.
   PubMed        
   
   

   
   Cancer Res

6. RIVERA-CARABALLO KA, Lee TJ, Sinha A, Orecchioni M, et al
   Oncolytic HSV-1-Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis.
   Cancer Res. 2025 Dec 18. doi: 10.1158/0008-5472.CAN-25-1402.
   PubMed         Abstract available
   
   
7. XIA Z, Liu W, Guo D, Chen L, et al
   circADAMTS12 Inhibits the Antitumor Activity of Microglia to Enable Metastatic Colonization in the Brain.
   Cancer Res. 2025;85:4977-4994.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

8. FUTCH HS, Jahangiri A, Zohdy YM, Wheelus J, et al
   Biopsy and laser ablation as a treatment strategy for pediatric brain incidentalomas.
   Childs Nerv Syst. 2025;41:419.
   PubMed         Abstract available
   
   

   
   Clin Neuropathol

9. KUMAR R N, Mawlong AK, Ghosh T, Raphael V, et al
   Rare encounter of spinal atypical teratoid/rhabdoid tumor in an adult: A case report and review of clinicopathological diagnostic pitfalls.
   Clin Neuropathol. 2025;44:253-260.
   PubMed         Abstract available
   
   

   
   Int J Cancer

10. SAEEDI E, Nemati S, Lotfi F, Domingues A, et al
    IRANCANSURV: A comprehensive analysis of childhood cancer survival in Iran.
    Int J Cancer. 2025 Sep 1. doi: 10.1002/ijc.70100.
    PubMed         Abstract available
    
    

    
    J Neurooncol

11. SAMPATH SG, Manriquez AH, Haile H, Botkiss M, et al
    Socioeconomic disparities in patient-reported outcomes, health literacy, and access to care among patients with primary brain tumors: findings from the All of Us Research Program.
    J Neurooncol. 2025;176:123.
    PubMed        
    
    
12. JHANDI S, Jhandi AS, Cannon DM, Burt LM, et al
    Stereotactic radiosurgery for radiation?induced meningiomas: long?term institutional outcomes with patient- and lesion?level analyses and an updated meta?analysis.
    J Neurooncol. 2025;176:122.
    PubMed        
    
    
13. BOFFELLI L, Fimiani C, Nunez NG, Kienzler JC, et al
    Synergy of radiotherapy, focused ultrasound, and immunotherapy in the treatment of brain metastases.
    J Neurooncol. 2025;176:124.
    PubMed         Abstract available
    
    
14. LEISTNER T, Terrapon APR, Hostettler IC, Bozinov O, et al
    Adverse events in meningioma surgery classified using the therapy-disability-neurology (TDN) grading system.
    J Neurooncol. 2025;176:125.
    PubMed         Abstract available
    
    
15. HU Y, Liu F, Mi R
    Glioma cells achieve malignant progression by fusion with macrophages to gain high SLC7A5 expression.
    J Neurooncol. 2025;176:126.
    PubMed        
    
    
16. SISTIAGA IL, Chen J, Mittelman L, Syed S, et al
    Connectomics in brain tumor surgery: large-scale clinical feasibility and hypothesis-generating tractometry findings.
    J Neurooncol. 2025;176:129.
    PubMed         Abstract available
    
    
17. PALERMO M, Massimi L, Tamburrini G, Olivi A, et al
    Algorithm-based assessment of T-cell dysfunction and exclusion to forecast ICB sensitivity in pediatric brain ependymoma.
    J Neurooncol. 2025;176:128.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

18. CHIANG WY, Li X, Tanaka R, Chiang J, et al
    Activated signaling pathways and metabolic processes in disseminating myxoid glioneuronal tumors.
    J Neuropathol Exp Neurol. 2025;84:1106-1112.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

19. 
    Retraction of: microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.
    Neuro Oncol. 2025 Dec 16:noaf260. doi: 10.1093.
    PubMed        
    
    
20. GREWAL EP, Steuart SJ, Liu B, Xie H, et al
    Tumor-Infiltrating Lymphocyte Therapy Generated from Melanoma Brain Metastasis: Proof-of-Concept for CNS-Derived Cellular Immunotherapy.
    Neuro Oncol. 2025 Dec 15:noaf288. doi: 10.1093.
    PubMed        
    
    
21. YOUSSEF G, Aquilanti E, Miller JJ, Lan Z, et al
    Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant Glioma.
    Neuro Oncol. 2025 Dec 15:noaf287. doi: 10.1093.
    PubMed         Abstract available
    
    
22. SCHIFF D
    "Vorasidenib and Low-Grade Glioma: INDIGO Incremental Insights".
    Neuro Oncol. 2025 Dec 14:noaf284. doi: 10.1093.
    PubMed        
    
    

    
    Neurology

23. MAQBOOL MA, Jenkins RB, Ida CM, Burns TC, et al
    Clinical Implications of Aberrant Retinoblastoma Signaling in Patients With Grade 4 IDH-Mutant Astrocytoma: A Retrospective Cohort Study.
    Neurology. 2026;106:e214478.
    PubMed         Abstract available
    
    

    
    Neurosurgery

24. OHARA K, Miyawaki S, Teranishi Y, Komura D, et al
    Genetic Analysis of Intracranial Schwannomas: Differential NF2 Alteration Frequencies in Nonvestibular Schwannomas Versus Vestibular Schwannomas.
    Neurosurgery. 2025 May 15. doi: 10.1227/neu.0000000000003508.
    PubMed         Abstract available
    
    

    
    Oncogene

25. SINGH A, Cheng D, Haltom AR, Yang Y, et al
    Identification of Raptor and GLI1 as USP37 substrates highlight its context-specific function in medulloblastoma cells.
    Oncogene. 2025 Dec 18. doi: 10.1038/s41388-025-03651.
    PubMed         Abstract available
    
    

    
    PLoS One

26. WU X, Li L, Zhan Z, Chang M, et al
    Predicting the influence of homologous recombination repair deficiency genes on glioma heterogeneity and patient prognosis using multi-omics analysis and machine learning.
    PLoS One. 2025;20:e0337731.
    PubMed         Abstract available
    
    
27. FARHAN AS, Khalid M, Manzoor U
    PRCnet: An efficient model for automatic detection of brain tumor in MRI images.
    PLoS One. 2025;20:e0292768.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.